According to MRFR analysis, the Global COVID-19 Sample Collection Kits Market is expected to register a CAGR of 5.20% during the forecast period of 2020 to 2027 and reach USD 4168.35 Million by 2027
Sample collection usually takes place in a doctor’s room or in a testing laboratory collection center where there are trained specimen collectors who perform the testing services.
The growth of the global COVID-19 sample collection kits market can be contributed for the high demand of sample collection kits, due to the outbreak of COVID-19 globally, and approval of new and advanced detection tests by regulatory authorities.
Furthermore, a rise in the detection of antibodies, an increase in government funding, and a large volume of products & usage rate of swabs are also expected to boost the market growth during the forecast period.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9769
However, a shortage of test-related supplies such as reverse transcription-polymerase chain reaction instruments, swabs, and virus control samples to control COVID-19, and lack of laboratory-based reagents are expected to restrain the growth of the global COVID-19 sample collection kits market.
Several market players such as Medline Industries, Inc., COPAN Diagnostics, and Becton, Dickinson, and Company, among others, currently dominate the global COVID-19 sample collection kits market.
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2020, owing to the outbreak of COVID-19 in the region. The COVID-19 sample collection kits market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European COVID-19 sample collection kits market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The COVID- 19 sample collection kits market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest-growing region. The COVID -19 sample collection kits market in the Middle East & Africa has been divided into the Middle East and Africa.
The global COVID-19 sample collection kits market has been segmented based on the product type, application, and end user.
On the basis of product type, the market has been segmented into swabs, viral transport media, blood collection kits, and others. The swabs segment is anticipated to be the fastest-growing segment. The swab segment is further divided into nasopharyngeal swabs and oropharyngeal swabs. The Centers for Disease Control and Prevention (CDC) has recommended collecting only nasopharyngeal swabs for testing the sample. The viral transport media is the largest growing segment.
Based on application, the market has been segmented into diagnostic, and research. The diagnostic segment is expected to be the fastest-growing, while the research segment is the largest growing segment.
The market based on end user has been segmented into hospitals & clinics, diagnostics centers, and others. The diagnostic center is anticipated to be the fastest-growing segment. The largest growing segment is hospitals & clinics.
Key Players
Some of the key players in the global COVID-19 sample collection kits market are Thermo Fisher Scientific, Inc. (US), Hardy Diagnostics (US), BNTX Inc. (Germany), Formlabs (US), Medline Industries, Inc. (US), HiMedia Laboratories (India), VIRCELL S.L. (Spain), Puritan Medical Products (US), COPAN Diagnostics (California), Becton, Dickinson, and Company (US), Laboratory Corporation of America Holdings (US), Lucence Diagnostics Pte Ltd. (California)
SegmentationBrowse More Details of the Report @ https://www.marketresearchfuture.com/reports/covid-19-sample-collection-kits-market-9769
No comments:
Post a Comment